Phase II clinical trial of human tumor necrosis factor Sertenef (PT-050) produced by recombinant DNA technology to skin malignant cancers.
1990 ◽
Vol 5
(1)
◽
pp. 210-226
◽
Shigeo IKEDA
◽
Kazuyuki ISHIHARA
H. Lenk
◽
St. Tanneberger
◽
U. M�ller
◽
J. Ebert
◽
T. Shiga
PatrickJ. Creaven
◽
DeanE. Brenner
◽
J.Wayne Cowens
◽
RobertP. Huben
◽
RichardM. Wolf
◽
...
1991 ◽
Vol 69
(6)
◽
pp. 261-268
◽
W. Fiedler
◽
W. Zeller
◽
C. -J. Peimann
◽
H. -J. Weh
◽
D. K. Hossfeld
PatrickJ. Creaven
◽
JohnE. Plager
◽
Sherry Dupere
◽
RobertP. Huben
◽
Hiroshi Takita
◽
...
1988 ◽
Vol 62
(12)
◽
pp. 2467-2471
◽
Edward T. Creagan
◽
John S. Kovach
◽
Charles G. Moertel
◽
Stephen Frytak
◽
Larry K. Kvols
1987 ◽
Vol 26
(5)
◽
pp. 1322-1326
◽
Janice M. Davis
◽
Michael A. Narachi
◽
N. Kirby Alton
◽
Tsutomu Arakawa
2002 ◽
Vol 21
(1)
◽
pp. 6
Slawomir Terlikowski
◽
Mariola Sulkowska
◽
Henryk F. Nowak
Thomas Pap
◽
Marvin Peters
◽
Berno Dankbar
2010 ◽
Vol 88
(2)
◽
pp. 139-145
◽
Shabnam Montazeri
◽
Sivalingam Nalliah
◽
Ammu Kutty Radhakrishnan